z-logo
open-access-imgOpen Access
Modulation of TNF ‐α mRNA stability by human antigen R and miR181s in sepsis‐induced immunoparalysis
Author(s) -
Dan Cao,
Jinjun Bian,
ZiChun Hua,
Lin Ma,
Wei Chen,
Xu Zhang,
Ri Zhou,
Shun Cheng,
WenZhu Sun,
QingCai Jiao,
Wu Yin
Publication year - 2015
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.201404797
Subject(s) - chemistry , messenger rna , ouabain , microbiology and biotechnology , in vivo , tumor necrosis factor alpha , immunology , medicine , biochemistry , biology , gene , sodium , organic chemistry
Immunoparalysis is an important pathological mechanism in sepsis. However, an effective small molecule therapy is lacking. Here, we show that ouabain, a Na + ,K + ‐ ATP ase ligand, can reverse immunoparalysis in vitro , in vivo , and in clinical samples. Notably, the effect of ouabain was critically dependent on TNF ‐α expression. However, ouabain had opposing effects on the stability of TNF ‐α mRNA : Ouabain triggered miR‐181 transcription, which promoted TNF ‐α mRNA degradation and induced immunoparalysis, and ouabain triggered the nuclear export of human antigen R (HuR), which stabilized TNF ‐α mRNA and suppressed immuno‐paralysis. Interestingly, because the miR‐181 binding site is located within the HuR binding site in the 3′‐untranslated region of TNF ‐α, in ouabain‐treated cells, HuR competed with miR‐181 for binding to TNF ‐α mRNA and recruited TNF ‐α mRNA to stress granules, thereby stabilizing TNF ‐α mRNA and reversing immunoparalysis. Ouabain also induced GM ‐ CSF and interferon‐γ expression in a HuR‐dependent manner. Hence, the fine‐tuning of TNF ‐α mRNA stability by HuR and miR181 plays a crucial role in immunoparalysis, and Na + ,K + ‐ ATP ase ligands are promising agents for immunoparalysis therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here